National Life Sciences Virtual Briefing

The event will include the following:

• Exit readiness: Explore the types of potential exits common in the UK Life Sciences sector and what you can be doing now to prepare for these. 
  • Including a panel discussion with Sam Taylor, a Partner from PwC UK's Life Sciences team, and Stifel Managing Director Nicholas Moore.
• Collaboration Agreements: 
  • Key strategic considerations for successful partnerships between Pharma and Biotech: a conversation with Iain Kilty, CEO of Sitryx
  • Perspectives on Tax and Accounting implications and what to think of in advance: comments from PwC UK Partners Rachael Palmer (Tax) and Daniel McNulty (Accounting Advisory)
• GenAI: What does it mean for the Life Sciences sector? How are leading organisations approaching GenAI innovation?